Type 2 Diabetes Jardiance vs. Farxiga: Similarities and Differences By Phuoc Anh (Anne) Nguyen, PharmD, MS, BCPS Updated on March 22, 2024 Medically reviewed by Alex Yampolsky, PharmD Print Table of Contents View All Table of Contents Uses & Ingredients Side Effects Dosage Which Is Better? Farxiga (dapagliflozin) and Jardiance (empagliflozin) are prescription medications that are commonly used for type 2 diabetes or heart failure. They belong to a class of medications known as sodium-glucose-co-transporter (SGLT2) inhibitors. Although similar in many ways, Farxiga and Jardiance primarily differ in some of their uses for heart-related complications. This article will cover the similarities and differences between Farxiga and Jardiance, including their uses, side effects, how to take them, and which might be better suited for your needs. Getty Images / Scott Olson / Staff Jardiance vs. Farxiga: Uses & Ingredients The key difference between Jardiance and Farxiga is their active ingredients. The active ingredient in Farxiga is called dapagliflozin, and Jardiance contains empagliflozin. However, Jardiance and Farxiga are both SGLT2 inhibitors and work similarly. These medications target a specific part of the kidneys responsible for glucose reabsorption. SGLT2 inhibitors block SGLT2 proteins to reduce glucose from being reabsorbed into the body. As a result, more glucose is released into the urine, which helps control glucose levels. Shared Uses The Food and Drug Administration (FDA) has approved the following uses for both Jardiance and Farxiga: Reduce the risk of heart-related death and hospitalization for heart failure in adults with heart failure Reduce the risk of sustained decline in kidney function, end-stage kidney disease, heart-related death, and hospitalization for heart failure in adults with chronic kidney disease (CKD) at risk of progression Add to diet and exercise to improve glycemic control in adults with type 2 diabetes Other Uses for Jardiance Jardiance is also approved to help reduce the risk of heart-related death in adults with type 2 diabetes and established heart disease. Other Uses for Farxiga Farxiga is also approved to reduce the risk of hospitalization for heart failure with type 2 diabetes and either established heart disease or multiple heart-related risk factors. Are Generics Available for Farxiga or Jardiance? Jardiance is only available under its brand name. On the other hand, dapagliflozin, the active ingredient in Farxiga, is available as a generic. This may make it more cost-effective for patients. Jardiance vs. Farxiga: Side Effect Comparison Since these medications work the same way, their side effects are fairly similar. Based on their clinical studies, both medications carry similar risks, and one is not any more tolerable than the other. Common Side Effects The following are common side effects shared by both medications: Nausea Increased urination Urinary tract infections (UTIs) Genital fungal infections Upper respiratory infections Severe Side Effects Due to how similar Farxiga and Jardiance are, the severe side effects you may experience are also similar. The following are severe side effects shared by both medications: Diabetic ketoacidosis (DKA) Serious UTIs, such as urosepsis (sepsis caused by UTIs) and pyelonephritis (kidney infection) Hypovolemia (loss of fluids) Hypoglycemia or low blood sugar in the blood How to Take Jardiance vs. Farxiga Both Jardiance and Farxiga are only available as oral tablets. Jardiance comes in the following tablet strengths: 10 milligrams (mg) and 25 mgFarxiga comes in the following tablet strengths: 5 mg and 10 mg Jardiance being available at higher doses does not mean it is more (or less) effective than Farxiga. When taking your medications, take them exactly as instructed by your healthcare provider. Dosing may be different depending on your specific health needs. The following table compares the dosage requirements for each medication and their shared uses. Type 2 Diabetes Heart Failure Chronic Kidney Disease Jardiance Initial dose is 10 mg once daily; your healthcare provider may increase your dose to 25 mg once daily if additional glycemic control is needed. 10 mg once daily 10 mg once daily Farxiga Initial dose is 5 mg once daily; your healthcare provider may increase your dose to 10 mg once daily if additional glycemic control is needed. 10 mg once daily 10 mg once daily Can You Switch Between Jardiance and Farxiga It is possible to switch between Jardiance and Farxiga. While this may be the case, it's important to consider whether there are true benefits in switching from one medication to the other. For instance, switching between them due to side effects may not be beneficial since they both have similar associated risks and side effects. Contact your healthcare provider to discuss which medication is best for you. Which Is Better: Farxiga or Jardiance? Both Farxiga and Jardiance are effective medications for type 2 diabetes and heart failure. Since Jardiance and Farxiga work similarly, one is not necessarily better. A clinical study confirmed that both medications are safe and effective as add-on therapies for further diabetes control. Summary Farxiga and Jardiance are medications that work very similarly and are effective for their FDA-approved uses. Both are approved to help manage type 2 diabetes and reduce heart failure complications. However, Farxiga is also prescribed to reduce the risk of hospitalization from heart failure and Jardiance is prescribed to reduce the risk of death from heart attacks, stroke, and heart failure. Jardiance is not available generically, while Farxiga is available under the generic name dapagliflozin, which may reduce patient cost. While both medications are highly effective, they do not come without risk. Ask your healthcare provider to help you determine which medication is better for you and your health condition. The author would like to recognize and thank Cody Ryan Thomas for contributing to this article. 5 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. DailyMed. Label: Jardiance-empagliflozin tablet, film coated. DailyMed. Label: Farxiga-dapagliflozin tablet, film coated. Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436-1446. doi:10.1056/NEJMoa2024816. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385(16):1451-1461. doi:10.1056/NEJMoa2107038 Hussain M, Atif M, Babar M, Akhtar L. Comparison of efficacy and safety profile of empagliflozin versus dapagliflozin as add on therapy in type 2 diabetic patients. J Ayub Med Coll Abbottabad. 2021;33(4):593-597. PMID: 35124914. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit